UPDATE: Adagio Said It Plans To Pause Patient Recruitment In Its Phase 2/3 COVID-19 Treatment Trial, Cites Emergence Of Omicron As Dominant Variant In South Africa

by | Dec 14, 2021 | Extra Jobs | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.